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Preoperative magnetic resonance imaging (MRI) is increasingly used for staging women with breast
cancer, including screening for occult ipsilateral or contralateral cancer.
If breast-conserving surgery is planned, a MRI examination should be performed in all ages women
with suspected breast cancer, especially those exhibiting dense or heterogeneously dense breast pa-
renchyma, for which the sensitivity of both ultrasonography and mammography is low.
MRI staging causes more extensive breast surgery in a signiﬁcative proportion of women by identi-
fying additional cancer.
If the ability to ﬁnd additional occult cancer is the true value of MRI, this is not inﬂuenced by patients'
ages. For this reason, preoperative MRI should be counseled to all women with breast cancer by clini-
cians, independently from the age, as the age alone does not preclude additional ﬁndings.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Breast cancer staging and surgical planning are affected by the
burden of pathologically proven cancer detected on clinical ex-
amination and/or imaging. Magnetic resonance imaging (MRI) has
superior sensitivity and accuracy for the detection of invasive and
in situ breast cancer when compared with physical examination,
mammography and ultrasound but can be limited in speciﬁcity. Theaging; FP, false positive; DW,
nt; US, ultrasound; CI, conﬁ-
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by Elsevier Ltd. All rights reserveduse of preoperative breast MR imaging for evaluating the extent of
disease remains controversial because clinical studies have not
deﬁnitively demonstrated MRI preoperative breast study to
improve overall survival, decrease re-excision rates or the costs of
care [1]. Patient age does not inﬂuence the value of breast MRI, in
the context of newly diagnosed breast cancer [2]. Evidence
consistently shows that MRI changes surgical management, usually
from breast conservation to more radical surgery resulting in
overtreatment without conclusively proven beneﬁcial effects on
such clinical outcomes as decrease in reoperation rates or improved
patient survival [3]. We discuss the usefulness of preoperative
magnetic resonance imaging in the surgical planning.
2. Results and discussion
In the absence of consensus about the role of preoperative MRI,
we review data on its detection capability and its impact on surgical
treatment. We outline that the assumptions behind the adoption of
MRI, namely that it will improve surgical planning andwill lead to a
reduction in re-excision surgery and in local recurrences, have not.
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that MRI changes surgical management, usually from breast con-
servation to more radical surgery; however, there is no evidence
that it improves surgical care or prognosis. Emerging data indicate
that MRI does not reduce re-excision rates and that it causes false
positives in terms of detection and unnecessary surgery [3,4];
overall there is little high-quality evidence at present to support the
routine use of preoperative MRI [4].
Preoperative MRI is increasingly used for staging women with
breast cancer, including screening for occult ipsilateral or contra-
lateral cancer. A meta-analysis by Houssami et al. [5] demonstrated
that preoperative breast MRI detected additional areas of disease in
the same breast in approximately 16% of women with newly
diagnosed breast cancer. A large study from 2007 revealed addi-
tional occult disease in the contralateral breast in 3% of newly
diagnosed breast cancer patients who underwent preoperative
breast MRI [6].
However MRI does not reliably distinguish benign from malig-
nant ﬁndings resulting in a high false positive (FP) rate [7], so it is a
highly sensitive but nonspeciﬁc method in detecting ipsi- or
contra-lateral lesions [8], so cytologic evaluation and core needle
biopsy remain mandatory when MRI ﬁndings suggest the need for
mastectomy [9]. A retrospective study demonstrated that the 40%
of women in all age groups (40e49; 50e59; 60e69; 70e79) shows
additional ﬁndings after preoperative MRI; mastectomy rates can
be decreased when these additional ﬁndings are furtherly studied
with needle biopsy [2].
If breast-conserving surgery is planned, a MRI examination
should be performed in all ages women with suspected breast
cancer, especially those exhibiting dense or heterogeneously dense
breast parenchyma, for which the sensitivity of both ultrasonog-
raphy and mammography is low [10] and in patients with doubts
about the local and distant extension of the tumor on conventional
assessment [11]. Ultrasound (US) is probably the standard imaging
procedure in most centers, and US-guided ﬁne-needle cytology can
be added if suspicious lymph nodes are found. However, US-guided
ﬁne-needle cytology remains an invasive method to diagnose a
metastasis and has showed relatively low sensitivity. In general,
diffusion-weighted (DW) MRI has become an emerging technique
for discriminating benign from malignant breast lesions in a short
imaging acquisition time. Chung J et al. [12] suggest an Apparent
Diffusion Coefﬁcient (ADC) cut-off value of 0.90  10.3 mm2/s
between metastatic and benign axillary lymph nodes. Using ADC
cut-off, reported sensitivity, speciﬁcity, and accuracy of DW MRI
were 100%, 83.3%, and 93.6%, respectively. The sensitivity, speci-
ﬁcity, and accuracy of US were 94.1%, 54.8%, and 79.1%, respectively.
Meta-analysis of three studies that compared MRI plus
mammography versus mammography alone showed the sensitivity
of MRI plus mammography as 94% (95% CI 86e98%) and the in-
cremental sensitivity of MRI as 58% (95% CI 47e70%). Incremental
sensitivity of MRI was lower when added to mammography plus
ultrasound (44%, 95% CI 27e61%) or to the combination of
mammography, ultrasound plus clinical breast examination
(31e33%). Estimates of screening speciﬁcity with MRI were less
consistent but suggested a 3e5-fold higher risk of patient recall for
investigation of false positive results [13]. No studies assessed
whether adding MRI reduces patient mortality, interval or
advanced breast cancer rates, and we did not ﬁnd strong evidence
that MRI leads to the detection of earlier stage disease.
In 2009, McGuire et al. [14] documented a steady rise in mas-
tectomy rates, from just over 30% in the late 1990s to approximately
60% in 2007 and Mahmood et al. [15] reported increased rates
especially among patients with early breast cancer. Similarly, the
rate of bilateral mastectomy has been increasing. Tuttle et al.
[16] demonstrated that the use of contralateral prophylacticmastectomy among patients with unilateral breast cancermarkedly
increased from 1998 to 2003, rising from 4.2% in 1998 to 11.0% in
2003 and a study from Memorial SloaneKettering demonstrated
that among nearly 3000 women presenting with unilateral breast
cancer between 1997 and 2005, 13.8% chose contralateral prophy-
lactic mastectomy [17]. Sorbero et al. [18] reported a nearly two-
times higher risk of contralateral prophylactic mastectomy when
preoperative breast MRI was performed. Although other factors
play a role, preoperative breast MRI was the strongest factor pre-
dicting for the use of contralateral prophylactic mastectomy, with
an odds ratio of over 3. Last, a recent German study of over 142,000
cases reported that breast MRI was independently associated with
mastectomy (odds ratio: 1.42; 95% CI: 1.36e1.47) [19].
3. Conclusion
The use of breastMRI has diffused rapidly. A recent study [20] on
over 52,000 women with newly diagnosed breast cancer between
2005 and 2008 showed that the use of breast MRI more than
doubled from 20 to 50%. The reasons for this rapid increase are not
entirely clear, especially given the lack of beneﬁt with regard to
long-term outcomes for breast cancer, its high FP rate and costs
[21]. MRI, infact, is a highly sensitive but non-speciﬁc exam. It
should be performed after clinical breast examination, US and
Mammography but its ﬁndings need to be conﬁrmed by pathologic
examination, especially core needle biopsy when mastectomy is
proposed as surgical treatment.
DW MRI of axillary lymph nodes can provide reliable informa-
tion for the differentiation of benign frommetastatic axillary lymph
nodes in invasive breast cancer patients [13].
Evidence supports that more extensive breast cancer surgery is
not necessarily better for women with respect to local recurrence
(in cases of wider local excision), distant metastases or other more
qualitative outcome measures, such as quality of life and body
image [21]. Besides if there is no improvement in clinical outcomes
and no short-term beneﬁts for patients, even ﬁnding more cancers
at an earlier stage could not be useful. It increases patient anxiety,
the need for additional imaging and biopsy, drive-up costs and
delay deﬁnitive surgical treatment [22e31]. MRI staging causes
more extensive breast surgery in a signiﬁcative proportion of
women by identifying additional cancer. If the ability to ﬁnd
additional occult cancer is the true value of MRI, this is not inﬂu-
enced by patients' ages. For this reason, preoperative MRI should be
counseled to all women with breast cancer by clinicians, indepen-
dently from the age, as the age alone does not preclude additional
ﬁndings [2].
Randomized clinical trials are needed to determine the clinical,
psychosocial and long-term effects of MRI in detecting additional
disease when this could change standard surgical treatment.
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